human alpha antitrypsin (CEVEC)

N/A

Report date: 2025/03/20 20:00:06

Base Information

Drug Namehuman alpha antitrypsin (CEVEC)
Drug Alias NamehAAT (CEVEC)
ClassificationBiologics > Protein drugs > Recombinant protein
Mechanisms of ActionAlpha-1-antiproteinase stimulants
TargetsAlpha-1-antiproteinase
Therapy Area/IndicationsGenetic Diseases, Inborn
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesCevec Pharmaceuticals
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesCevec Pharmaceuticals
Active IndicationsN/A
Inactive IndicationsGenetic Diseases, Inborn

Other Information

ATC CodeN/A
Related LinksN/A